impact factor, citescore
logo
 

shopping cart

Confirmation
purchase
Item
Code
Item DescriptionPrice
CER13926A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale20.00 €
 Subtotal 20.00 €